Sarepta Therapeutics

Business

Sarepta Therapeutics Surges After FDA Expands Approval for DMD Drug ELEVIDYS

Sarepta Therapeutics (NASDAQ), a leader in precision genetic medicine for rare diseases, saw a significant rise in after-hours trading on…

Read More »
Back to top button